Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating Apo 2L levels decreased in genotype II hepatitis C with pegylated interferon-2 alpha treatment.

Le infezioni in medicina - 1 Dec 2014

Yalcin Arzu Didem, Celik Betul, Kose Sukran, Seyman Derya, Gumuslu Saadet, Yalcin Ata Nevzat

Abstract excerpt

Pro-inflammatory factors regulated by TRAIL in vivo may lead to the development of novel therapeutic strategies for diseases as diverse as infection, autoimmunity and allergy. In this study we aimed to investigate the relationship between IFN treatment response, HCV viral load and sApo 2L levels. Eleven HCV-treatment naive HCV-infected patients were treated with pegIFN alfa-2a. Intensive serum circulating Apo 2L...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Polyethylene Glycols

Share to Ribavirin

Share to TNF-Related Apoptosis-Inducing Ligand

Share to Turkey

Share to Viral Load

Source

Identifiers

PMID: 25551843

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Circulating Apo 2L levels decreased in genotype II hepatitis C with pegylated interferon-2 alpha treatment.PMID 25551843Read ↗

Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4.Semantic proximity Read ↗

Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a/2b patients with chronic hepatitis C.Semantic proximity Read ↗

Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy.Semantic proximity Read ↗

Inflammation and repair in viral hepatitis C.Semantic proximity Read ↗

The Role of Type III Interferons in Hepatitis C Virus Infection and TherapySemantic proximity Read ↗

Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming.Semantic proximity Read ↗

Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C.Semantic proximity Read ↗

Digging more in the genetic risk prediction of hepatitis C virus epidemic in Egypt: Apoptosis genes polymorphisms in the susceptibility of hepatitis C virus and association with viral load.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.